Pim-1 oncoprotein is a serine/threonine kinase that can closely cooperate with c-Myc in lymphomagenesis, as does Bcl-2. Although the molecular mechanism of this cooperative transformation remains unknown, it is speculated that, similar to Bcl-2, Pim-1 contributes to transformation by inhibiting apoptosis. In this study, therefore, we examined the eect of Pim-1 expression on c-Myc-mediated apoptosis of Rat-1 ®broblasts triggered by serum deprivation. Our results showed that, rather than inhibiting apoptosis, Pim-1 expression stimulated cMyc-mediated apoptosis in Rat-1 ®broblasts. Pim-1 stimulated c-Myc-mediated apoptosis through an enhancement of the c-Myc-mediated activation of caspase-3 (CPP32)-like proteases, since the suppression of this activity by a speci®c caspase inhibitor abolished the apoptosis stimulation by Pim-1. A kinase-defective Pim-1 mutant failed to stimulate c-Myc-mediated apoptosis, and Pim-1 expression alone in the absence of c-Myc overexpression did not induce apoptosis of serumdeprived Rat-1 cells, indicating that the kinase activity of Pim-1 and the activated c-Myc signaling pathway were required for apoptosis stimulation by Pim-1. Together, these results suggest that Pim-1 oncoprotein stimulates as a serine/threonine kinase the death signaling elicited by c-Myc at a step upstream of caspase-3-like protease activation in Rat-1 ®broblasts. Our results also suggest that Pim-1 kinase might function cooperatively with c-Myc through the phosphorylation of a factor(s) which regulates the common signaling pathway involved in c-Myc-mediated apoptosis and transformation.
Introduction
The pim-1 oncogene was ®rst identi®ed by its activation by proviral insertion in murine leukemia virus-induced T cell lymphomas (Cuypers et al., 1984; Selten et al., 1985) . The oncogenic potential of pim-1 was subsequently demonstrated in the Em-pim-1 transgenic mice (van Lohuizen et al., 1989) . Interestingly, either c-myc or N-myc was activated by proviral insertion in all T cell lymphomas that developed in the Em-pim-1 transgenic mice (van Lohuizen et al., 1989) . Conversely, pre-B cell lymphomagenesis in Em-myc transgenic mice was accelerated by the infection of Molony murine leukemia virus, whose provirus was frequently inserted near the pim-1 gene . Moreover, double transgenic Em-myc, Empim-1 mice exhibit pre-B cell leukemia in utero . These ®ndings clearly indicated that pim-1 can closely and speci®cally cooperate with cmyc in tumorigenesis, though the molecular mechanism of this cooperation remains unknown. It has been shown that pim-1 expression rescues both lymph node cells from rapid apoptosis in vitro and CD4 + /CD8 + double-positive thymocytes from dexamethasone-induced apoptosis in vivo in Em-pim-1 lpr/lpr mice (MoÈ roÈ y et al., 1993) . By analogy to the bcl-2 protooncogene, which is considered to contribute to cellular transformation by inhibiting apoptosis, it has been suggested that pim-1 may also contribute to transformation by inhibiting apoptosis (MoÈ roÈ y et al., 1993) .
The c-myc proto-oncogene was initially identi®ed as the cellular homolog of the viral oncogene v-myc, and the critical role of c-myc in tumorigenesis has been well established (Henriksson and LuÈ scher, 1996) . However, it has been also demonstrated that the deregulated expression of c-Myc accelerates or induces apoptotic cell death in cells deprived of growth factors (Askew et al., 1991; Evan et al., 1992) . Thus, c-myc is not only a positive regulator of cell proliferation and transformation but also a positive regulator of apoptotic cell death. It is therefore expected that the inhibition of cMyc-mediated apoptosis would enhance the oncogenic ability of c-Myc. Consistent with this idea, Bcl-2, which eectively inhibits c-Myc-mediated apoptosis (Fanidi et al., 1992; Bissonnette et al., 1992; Wagner et al., 1993) , cooperates with c-Myc in the malignant transformation of lymphoid cells in transgenic mice (Strasser et al., 1990) .
To gain insights into the mechanism of cooperation between pim-1 and c-myc, we investigated the role of Pim-1 in c-Myc-mediated apoptosis. Here we show that Pim-1 acts as an activator rather than an inhibitor of cMyc-mediated apoptosis induced in Rat-1 ®broblasts by serum deprivation. We show that Pim-1 does so through an enhancement of the c-Myc-mediated activation of caspase-3 (CPP32)-like proteases. In addition, using a kinase-defective mutant of Pim-1, we demonstrate that the kinase activity of Pim-1 is required for this enhancement of the c-Myc-mediated activation of caspase-3-like proteases causing apoptotic cell death. Our results indicate that oncoprotein Pim-1 as a serine/threonine kinase augments the death signal elicited by c-Myc at a step upstream of caspase-3-like protease activation in Rat-1 ®broblasts. Our ®ndings also suggest that pim-1 might cooperate with c-myc by stimulation of the intracellular signaling required for cMyc-mediated transformation and apoptosis.
Results
Establishment of Rat-1 transfectants that stably express c-Myc, Pim-1, or both
To investigate the eect of Pim-1 expression on c-Mycmediated apoptosis, we used the experimental system described by Evan et al. (1992) , in which the overexpression of c-Myc causes apoptosis of serumdeprived Rat-1 ®broblasts. We ®rst established Rat-1 clones that stably express c-Myc (Rat-1/c-Myc) by transfecting Rat-1 cells with a plasmid vector (pCEP4cmyc) carrying human c-myc cDNA connected with the cytomegalovirus (CMV) promoter. Consistent with the previous report , the Rat-1/ c-Myc clones could grow normally in medium containing 10% fetal calf serum (FCS) but underwent typical apoptosis when deprived of serum growth factors. Among the established clones, a representative clone (Rat-1/c-Myc#7) was used for the subsequent assays. To examine the possible involvement of Pim-1 in cMyc-mediated apoptosis, we transfected pcDNA3pim-1 expressing rat pim-1 cDNA under the control of CMV promoter into parental Rat-1 and Rat-1/c-Myc#7 cells to isolate Rat-1/Pim-1 and Rat-1/c-Myc/Pim-1 clones, respectively. After selection by G418, stable transfectants were obtained and examined by Northern blot analysis for pim-1 mRNA expression. In addition to the low level of endogenous pim-1 transcript, Rat-1/ Pim-1#1, Rat-1/Pim-1#2, Rat-1/c-Myc/Pim-1#3, and Rat-1/c-Myc/Pim-1#4 cells expressed signi®cantly high levels of transfected pim-1 (Figure 1a , top panel). In contrast, Rat-1/c-Myc/Pim-1#1 and Rat-1/c-Myc/Pim-1#2 did not express a detectable level of transfected pim-1, despite the introduction of pim-1 expression vector. We con®rmed that Pim-1 expression does not signi®cantly alter the level of c-myc expression either at the mRNA level ( Figure 1a , middle panel) or at the protein level (Figure 1b) . Consistent with the previous observation that coexpression of c-Myc and Pim-1 does not transform cultured cells (Henriksson and LuÈ scher, 1996) , the Rat-1 transfectants expressing both c-Myc and Pim-1 did not form transformed foci even when passaged for longer than 1 month. This ®nding suggests that their expression alone may not be sucient for full transformation, and that additional cellular backgrounds or environmental conditions may be required.
Pim-1 stimulates rather than inhibits c-Myc-mediated apoptosis
Using the established clones, we examined whether Pim-1 inhibits c-Myc-mediated apoptosis. When Rat-1/ c-Myc#7 cells were deprived of serum growth factors (cultured in medium containing 0.1% FCS), many cells lost adherence and became round and shrunken within 24 h, as shown in Figure 2a . This process was accompanied by nuclear condensation and fragmentation, indicating that the cells were dying by apoptosis. When Rat-1/c-Myc/Pim-1#4 cells that overexpress both c-Myc and Pim-1 were similarly deprived of serum growth factors, surprisingly, a signi®cantly larger number of dying cells was produced compared to the Rat-1/c-Myc#7 cells (Figure 2a) . The cell death of Rat-1/c-Myc/Pim-1#4 cells was also accompanied by apoptotic phenotypes as found in Rat-1/c-Myc cells, including round and shrunken morphology (Figure 2a) , chromatin condensation and/or nuclear fragmentation (Figure 2b ), and positive staining by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) (Figure 2c ). Quantitation of apoptotic cells by TUNEL assay revealed that, when deprived of serum, Rat-1/c-Myc/Pim-1#4 cells produced nearly twice as many TUNEL-positive cells as Rat-1/c-Myc#7 cells (Figure 2d ). These results suggested that the expression of Pim-1 stimulates c-Mycmediated apoptosis rather than inhibiting it. To con®rm that the stimulation of apoptosis induction is dependent on Pim-1 expression, we analysed other Rat-1/c-Myc/Pim-1 clones. As shown in Figure 2e , when deprived of serum, the Rat-1/c-Myc/Pim-1 clones expressing Pim-1 (#3, #4) produced approximately twice as many apoptotic cells as did Rat-1/c-Myc#7, whereas Rat-1/c-Myc/Pim-1 clones not expressing Pim-
Figure 1 Characterization of Rat-1 transfectants. (a) Expression of the transfected pim-1 and c-myc mRNA products. Total RNAs (15 mg) were extracted from the indicated cells and subjected to Northern blot analysis using 32 P-labeled rat pim-1 cDNA as a probe (top panel). The same ®lter was deprobed and subsequently hybridized with human c-myc cDNA probe (middle panel). The bottom panel shows the ethidium bromide-stained gel to ascertain the quality and quantity of the RNA loaded. (b) Expression of cMyc protein in the transfectants. Cell lysates were prepared from the indicated cells, and 40 mg of the cell lysates were subjected to Western blot analysis using anti-c-Myc polyclonal antibody 1 (#1,#2) produced numbers of apoptotic cells similar to that produced by Rat-1/c-Myc#7. Taking into account that these Rat-1/c-Myc/Pim-1 clones express comparable levels of c-Myc (Figure 1b) , this result implies that the stimulation of apoptosis is dependent on Pim-1 expression and not due to clonal variation. Given that Pim-1 stimulates c-Myc-mediated apoptosis, we next asked whether the expression of Pim-1 alone can mediate the apoptosis of Rat-1 cells triggered by serum deprivation. When Rat-1/Pim-1 clones (#1,#2) were deprived of serum, very few apoptotic cells were produced as with parental Rat-1 cells (Figure 2e ). Because these Rat-1/Pim-1 clones express levels of pim-1 mRNA similar to those of Rat-1/c-Myc/Pim-1#3 and #4 (Figure 1a ), this result indicates that Pim-1 by itself is not able to induce apoptosis in serum-deprived Rat-1 cells. Taken together, these results suggest that although Pim-1 by itself cannot cause apoptosis under low serum culture conditions, it stimulates c-Mycmediated apoptosis in serum-deprived Rat-1 fibroblasts.
Serine/threonine kinase activity of Pim-1 is essential for stimulating c-Myc-mediated apoptosis It has been shown that Pim-1 is a protein-serine/ threonine kinase (Telerman et al., 1988; Hoover et al., 1991; Padma and Nagarajan, 1991; Saris et al., 1991) . We therefore investigated whether the serine/threonine kinase activity of Pim-1 is required for the stimulation of c-Myc-mediated apoptosis. For this purpose, we created a kinase-defective Pim-1 mutant (Pim-1K67M) by the conversion of Met at position 67 of the protein into Lys by site-directed mutagenesis. This Pim-1K67M mutant has been shown to lose its intrinsic kinase activity in in vitro kinase assays (Saris et al., 1991; Friedmann et al., 1992) . We transfected pcDNA3pim-1K67M expressing this Pim-1 mutant into Rat-1/c-Myc#7 cells and isolated stable transfectants (Rat-1/c-Myc/Pim-1K67M). Among the transfectants, Rat-1/c-Myc/Pim-1K67M#7 and #16 expressed levels of exogenous pim-1 mRNA comparable to that of Rat-1/c-Myc/Pim-1#4 (Figure 3a ). When Rat-1/cMyc/Pim-1K67M#7 and #16 were cultured in medium containing 0.1% FCS, these clones produced fewer apoptotic cells than did the Rat-1/c-Myc/Pim-1#4 cells, and the number of apoptotic cells was comparable to or slightly smaller than that produced by Rat-1/c-Myc#7 cells (Figure 3c ). Since Rat-1/cMyc/Pim-1K67M#7 and #16 cells expressed levels of c-Myc protein similar to that expressed by the Rat-1/ c-Myc#7 cells (Figure 3b ), these results indicate that the serine/threonine kinase activity of Pim-1 is required for the stimulation of c-Myc-mediated apoptosis of Rat-1 cells triggered by serum deprivation and also suggest that this kinase-defective Pim-1 mutant (Pim-1K67M) may cause a dominant-negative eect on c-Myc-mediated apoptosis.
Pim-1 does not aect the expression levels of p53, p27 Kip1 , and Bcl-2 family proteins
We next examined the eect of Pim-1 kinase on the expression regulation of factors that may be involved in the downstream processes of c-Myc-mediated apoptosis. It has been reported that wild-type p53 is required for c-Myc-mediated apoptosis (Hermeking and Eick, 1994; Wagner et al., 1994) , during which p53 protein is stabilized by c-Myc expression (Hermeking and Eick, 1994) . We therefore examined the expression level of p53 protein in Rat-1 cells expressing c-myc and/or pim-1. As Figure 4a (top panel) shows, the expression level of p53 was very low in both parental Rat-1 cells and in Rat-1 transfectants. In some experiments, the p53 protein level appeared slightly higher in c-myc transfectants (data not shown), but the p53 protein level was not altered by Pim-1 expression.
It has been reported that the expression of p27 cyclin-dependent kinase (cdk) inhibitor is under negative posttranslational regulation by c-Myc (Steiner et al., 1995) . Since p27 has been shown to confer resistance against anticancer agents to tumor cells (Croix et al., 1996) , it appeared likely that p27 has antiapoptotic activity similar to other cdk inhibitors such as p16 and p21 (Wang and Walsh, 1996; Poluha et al., 1996) . We therefore hypothesized that c-Myc may mediate apoptosis through the down-regulation of p27, and that Pim-1 might facilitate this process. To test this idea, we examined the expression level of p27 protein in the Rat-1 transfectants. Although serum deprivation slightly increased the p27 expression, it was not signi®cantly altered by Pim-1 expression or even by c-Myc (Figure 4a , middle panel).
We then turned to Bcl-2 family proteins, which have been shown to positively or negatively regulate apoptosis triggered by various stimuli (Reed, 1994 ). We examined the expression level of the Bcl-2 family proteins in Rat-1 cells undergoing c-Myc-mediated apoptosis and the eect of Pim-1 on their expression. As shown in Figure 4b , Pim-1 expression did not aect the expression levels of the Bcl-2 family proteins Bcl-2 (Tsujimoto et al., 1985) , Bax (Oltvai et al., 1993) , Bcl-x L (Boise et al., 1993) , and Bak (Farrow et al., 1995; Chittenden et al., 1995; Kiefer et al., 1995) . In addition, their expression levels did not change remarkably before and after apoptosis induction by serum deprivation.
Pim-1 stimulates c-Myc-mediated apoptosis through the enhancement of the c-Myc-mediated activation of caspase-3-like proteases
We recently found that caspase-3-like proteases are activated and are required for transduction of the death signal in Myc-mediated apoptosis under low serum culture conditions (SK et al., submitted for publication) as well as in Fas-and tumor necrosis factor (TNF)-mediated apoptosis (Tewari et al., 1995; Enari et al., 1996) . We therefore investigated whether the stimulation of c-Myc-mediated apoptosis by Pim-1 depends on activation of caspase-3-like proteases. For this purpose, we ®rst examined the caspase-3-like protease activity in parental Rat-1, Rat-1/Pim-1#1, Rat-1/c-Myc#7, Rat-1/c-Myc/Pim-1K67M#16, and Rat-1/c-Myc/Pim-1#4 cells before and after apoptosis induction (Figure 5a ). Consistent with our previous observation, caspase-3-like protease activity was signi®cantly induced in Rat-1/c-Myc#7 cells compared to Rat-1 parental cells 24 h after serum deprivation. Compared to the Rat-1/c-Myc#7 cells, the caspase-3-like protease activity induced in the Rat-1/c-Myc/Pim-1#4 cells 24 h after serum deprivation was approximately twofold higher, and the caspase-3-like protease activity in the Rat-1/c-Myc/Pim-1K67M#16 cells was comparable to or slightly lower than that in the Rat-1/c-Myc#7 cells. The expression of Pim-1 alone failed to enhance the activation of caspase-3-like proteases upon serum deprivation, in accord with its inability to induce apoptosis by itself. Thus, the caspase-3-like protease activity correlated well with the amounts of cell death induced in these clones (compare Figures 2e and 3c with Figure 5a ). These results suggested that Pim-1 kinase stimulates cMyc-mediated apoptosis through the enhancement of c-Myc-mediated activation of caspase-3-like proteases. If this is the case, then the inhibition of caspase-3-like protease activity should also inhibit the stimulation of c-Myc-mediated apoptosis by Pim-1. To test this idea, we treated Rat-1/c-Myc#7 and Rat-1/c-Myc/Pim-1#4 cells with a speci®c caspase inhibitor Z-Asp-CH 2 -DCB (Dolle et al., 1994; Mashima et al., 1995) . In the presence of 25 mg/ml of Z-Asp-CH 2 -DCB, the induction of caspase-3-like protease activity by serum deprivation was completely inhibited in both Rat-1/ c-Myc#7 and Rat-1/c-Myc/Pim-1#4 cells (Figure 5b ). Under this concentration of Z-Asp-CH 2 -DCB, apoptosis induction was eectively inhibited to a similar level in both transfectants (Figure 5c and d) . These results indicate that the enhancement of c-Mycmediated apoptosis by Pim-1 is dependent on caspase-3-like protease activity, and the results strongly support the idea that Pim-1 oncoprotein stimulates c-Myc-mediated apoptosis in Rat-1 fibroblasts through an enhancement of the c-Myc-mediated activation of caspase-3-like proteases. 
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Discussion
In a variety of cancers, the apoptotic signaling pathway is frequently suppressed by the expression of survival factors and/or by the inactivation of deathpromoting factors, indicating that the disruption of apoptotic signaling plays an important role in carcinogenesis. In the present study, we therefore examined whether the oncoprotein Pim-1, which cooperates with c-Myc in oncogenesis, suppresses cMyc-mediated apoptosis as does Bcl-2. However, our results indicated that Pim-1 acts as an activator rather than an inhibitor of c-Myc-mediated Rat-1 cell death triggered by serum deprivation. Our results also indicated that Pim-1 stimulates the intracellular signaling elicited by c-Myc at a step upstream of caspase-3-like protease activation. These ®ndings appear to suggest another possible mechanism for cooperative transformation by c-Myc and Pim-1 distinct from the mechanism operating in cotransfor- mation by c-Myc and Bcl-2. A previous study showed that the regions required for c-Myc-mediated apoptosis and transformation are tightly coupled . In addition, both c-Myc-mediated apoptosis and transformation require dimerization with Max (Amati et al., 1993a,b) . These lines of evidence suggest that the signals elicited by c-Myc leading to apoptosis and transformation follow a common pathway at least initially and then diverge. Therefore, Pim-1 kinase may possibly interact with and stimulate the common signaling pathway for c-Myc-mediated apoptosis and transformation. Based on this idea, one could clearly understand why Pim-1 cooperates with c-Myc both in apoptosis and transformation. Moreover, it provides a better explanation for the recent observation that Bcl-2 cooperates with Pim-1 in lymphomagenesis in transgenic mice (Acton et al., 1992) . If one assumes that Pim-1 contributes to lymphomagenesis solely by inhibiting apoptosis, it would be rather dicult to understand why Pim-1 should so eciently cooperate with an antiapoptotic protein Bcl-2 to transform cells. In addition, ZoÈ rnig et al. (1996) reported that another cooperating molecule such as G®-1 is required for lymphomagenesis in myc/pim-1 double transgenic mice. G®-1 is a zinc ®nger protein that can repress the transcription of the bax gene and has been shown to inhibit cell death of thymocytes (ZoÈ rnig et al., 1996; Grimes et al., 1996) . This cooperation would be well understood if one supposes that Pim-1 stimulates Myc-mediated signaling common to transformation and apoptosis and that G®-1 selectively suppresses the signaling pathway leading to apoptosis. Here, it should be noted that c-Myc and Pim-1 is not sucient for lymphomagenesis and that another cooperating molecule represented by G®-1 is required (ZoÈ rnig et al., 1996) . This is consistent with a previous observation and our results that coexpression of cMyc and Pim-1 does not transform cultured cell lines (1993) that Pim-1 contributes to lymphomagenesis by apoptosis inhibition and our idea may appear somewhat contradictory, it should be emphasized that they are not mutually exclusive. It is quite possible that Pim-1 contributes to lymphomagenesis by stimulating the c-Myc-mediated signaling and by inhibiting lymphocyte apoptosis through a distinct signaling pathway at the same time. To elucidate the exact mechanism of cooperation between c-Myc and Pim-1 in lymphomagenesis, it would be important to investigate whether Pim-1 stimulates c-Myc-mediated signaling in lymphocytes, and if so, how. It would be also of interest to examine whether Pim-1 cooperates with other oncoproteins in cellular transformation and apoptosis or this cooperative eect of Pim-1 is speci®c to c-Myc. To understand the mechanism by which Pim-1 modulates c-Myc-mediated apoptosis, we examined in this study the expression level of p53 tumor suppressor protein, p27 cdk inhibitor, and Bcl-2 family proteins that might be implicated in c-Myc-mediated apoptosis. However, none of these were under the control of Pim-1, although we cannot exclude the possibility that Pim-1 regulates their activity without altering their expression levels. We therefore examined the eect of Pim-1 expression on the activity of caspase-3-like proteases which we have recently found to play an essential role in c-Myc-mediated apoptosis (SK et al., submitted for publication). The results indicated that the stimulation of c-Myc-mediated apoptosis by Pim-1 was dependent on the ability of Pim-1 to regulate the caspase-3-like protease activity, suggesting that Pim-1 functions upstream of caspase-3-like protease activation in the signaling pathway for c-Myc.
The result that a kinase-defective Pim-1 mutant did not stimulate c-Myc-mediated apoptosis indicates that Pim-1 stimulates c-Myc-mediated apoptosis by phosphorylation of its target molecule. Interestingly, the expression of Pim-1 per se induced neither caspase-3-like protease activity nor apoptosis in serum-deprived Rat-1 cells. These ®ndings suggest that the target molecule(s) of Pim-1 kinase is absent or inaccessible to Pim-1 in the absence of c-Myc overexpression. Under c-Myc overexpression, such a molecule(s) may be abundant or accessible to Pim-1 and becomes activated after phosphorylation by Pim-1. Then, what is the target molecule of Pim-1 kinase that can modulate c-Mycmediated apoptosis? Since c-Myc contains several sites that can be phosphorylated by a number of kinases in the transcriptional activation domain (Henriksson and LuÈ scher, 1996) , one may speculate that c-Myc itself is the target of Pim-1. However, the possibility that Pim-1 directly phosphorylates c-Myc and stimulates its activity as a transcriptional activator is unlikely based on the following lines of evidence. First, c-Myc does not contain the substrate recognition sequence for Pim-1 kinase, (Arg/Lys) 3 -X-Ser/Thr-X' (X' is likely neither a basic nor a large hydrophobic residue) (Friedmann et al., 1992) . Indeed, according to Saris et al. (1991) , c-Myc protein was not phosphorylated by Pim-1 in vitro. Second, the coexpression of Pim-1 did not enhance the transcriptional activation of a reporter plasmid by cMyc in transient chloramphenicol acetyl-transferase assays (TM, unpublished data). As another possibility, the transcriptional targets of c-Myc might be regulated by Pim-1 kinase, since c-Myc is considered to induce apoptosis by activating the transcription of its target genes (Henriksson and LuÈ scher, 1996) . To date, ECA39 (Benvenisty et al., 1992) , ornithine decarboxylase (ODC) (Bello-Fernandez et al., 1993) , p53 (Reisman et al., 1993) , a-prothymosin (Gaubatz et al., 1994) , cad (Miltenberger et al., 1995) , and Cdc25A (Galaktionov et al., 1996) have been shown to be the genes transcriptionally activated by c-Myc. Among them, Cdc25A cell-cycle phosphatase has only recently been recognized as a candidate mediator molecule of c-Mycmediated apoptosis. Since Cdc25A has transforming activity as well (Galaktionov et al., 1995a) , Cdc25A may be one of the key molecules that transduce the signal , and Bcl-2-related proteins are not aected by Pim-1. Cell lysates were prepared from the indicated cells which were cultured in medium containing 10% FCS [serum (+)] or 0.1% FCS [serum (7)] for 24 h, and the cell lysates (40 mg) were subjected to Western blot analysis. Antibodies for p53, p27 , and c-Myc were used in (a) and antibodies for Bcl-2, Bcl-x, Bax, and Bak were used in (b). A cell lysate prepared from U251 human glioma (40 mg) was loaded to serve as a positive control for p53 protein Interestingly, Cdc25A contains a peptide sequence that can be phosphorylated by Pim-1 kinase (TM, unpublished observation). It would therefore be possible that Pim-1 stimulates c-Myc-mediated apoptosis through the phosphorylation and activation of the phosphatase activity of Cdc25A, similar to another serine/threonine kinase, Raf-1, which has been shown to bind and activate the phosphatase activity of Cdc25A (Galaktionov et al., 1995b) . We are now performing experiments to test this idea. Whether or not Cdc25A is a substrate of Pim-1 kinase, the identi®cation of the phosphorylation targets of Pim-1 will provide important information in elucidating the signaling pathway involved in c-Mycmediated apoptosis and transformation.
Materials and methods

Cell culture
Unless otherwise indicated, Rat-1 cells and their derivative clones were cultured in Dulbecco's modi®ed Eagle's medium (DMEM) (Nissui) supplemented with 10% FCS (Immuno-Biological Laboratories), 100 U/ml of penicillin G and 100 mg/ml of streptomycin (Life Technologies), and 0.6 mg/ml glutamine (Nissui), at 378C in 5% CO 2 . Stable Rat-1 transfectants were maintained in the presence of appropriate combinations of the selection drugs G418 (200 mg/ml, Life Technologies) and hygromycin B (200 U/ ml, Calbiochem).
Plasmids and transfection
To amplify rat pim-1 cDNA, a set of oligodeoxynucleotide primers were synthesized based on the rat cDNA sequence reported previously by Wingett et al. (1992) : forward primer 5'-TCGAATTCGATGCTCTTGTCCAAGATC-3' and reverse primer 5'-TCGAATTCTGTCCCTGCATCG-TAGAGC-3', each of which contained a restriction enzyme site (EcoRI) at their 5' termini to facilitate the subcloning of the PCR product. The pim-1 cDNA ampli®ed by this primer set is expected to encode only the 34 kDa Pim-1 protein (Saris et al., 1991) . Poly(A) + RNA (1 mg) from rat thymus was subjected to reverse transcription, and the product was ampli®ed by PCR using the above primers. The ampli®ed rat pim-1 cDNA was subcloned into the EcoRI site of the expression vector pcDNA3 (Invitrogen) to construct pcDNA3pim-1. pcDNA3pim-1K67M was constructed by using the Quick Change site-directed mutagenesis kit (Stratagene) according to the manufacturer's protocol. For this mutagenesis, pcDNA3pim-1 was used as a template, and synthetic oligodeoxynucleotides 5' -GCCGGTGGCCATCATGCACGTGGAGAAGG -3' and 5' -CCTTCTCCACGTGCATGATGGCCACCGGC-3' were used as sense and antisense primers, respectively. The plasmid pCEP4cmyc, which drives the expression of human c-myc cDNA, has been described (Asai et al., 1994) . Rat-1/ c-Myc cells were established by transfecting pCEP4cmyc into Rat-1 cells by the lipofectin-mediated transfection method described previously (Kitanaka et al., 1995) and selection against hygromycin B (400 U/ml). The plasmids pcDNA3pim-1 and pcDNA3pim-1K67M were transfected into Rat-1 cells or Rat-1/c-Myc#7 cells, and resistant clones were selected against G418 (400 mg/ml).
Northern blotting
Total RNA was extracted from exponentially growing cells using the ISOGEN reagent according to the manufacturer's protocol (Nippon Gene). The RNA samples (15 mg/ lane) were separated in a 1.9% formaldehyde-1.0% agarose gel and transferred to a nylon membrane. Rat pim-1 and human c-myc cDNAs were labeled with 32 P-dCTP using the Oligolabeling kit (Pharmacia) according to the manufacturer's protocol. The hybridization and washing conditions were as described (Kitanaka et al., 1995) .
Western blotting
Cells (7610 5 ) were seeded into 100 mm dishes and transferred 24 h later to medium containing either 10% or 0.1% FCS. After being cultured for another 24 h, the cells were lysed in 0.1 ml of lysis buer (25 mM Tris-HCl [pH 7.6], 50 mM NaCl, 2% NP-40, 0.5% sodium deoxycholate, 0.2% SDS). After centrifugation, the supernatants were collected as protein samples. Protein samples (40 mg protein/lane) were loaded and separated by electrophoresis in an SDS-polyacrylamide gel. Proteins were electrically transferred to a nitrocellulose membrane. The membrane was probed with the appropriate primary antibodies (N-262 for c-Myc, N-19 for Bcl-2, N-20 for Bax, G-23 for Bak, S-18 for Bcl-x, C-19 for p27 [Santa Cruz] and Ab-1 for p53 [Oncogene Science]) in antibody buer (PBS containing 5% non-fat milk and 0.1% Tween 20) for 2 h at room temperature. After washing with antibody buer, the membrane was subsequently incubated with HRP-Rat Anti-Rabbit IgG or HRP-Goat Anti-Mouse IgG (ZYMED) as a secondary antibody for 1 h at room temperature. The membrane was then washed with antibody buer lacking non-fat milk, and bound antibodies were detected by an ECL Western blotting detection reagent (Amersham).
Cell death assays
For serum deprivation, cells (5.0610 5 ) were seeded into 100 mm dishes and transferred 24 h later to medium containing 0.1% FCS. Apoptotic cells were identi®ed by their loss of adherence, and apoptotic change of the nuclei was con®rmed by staining the cells with 0.5 mg/ml of acridine orange (Sigma). Apoptosis was also con®rmed by TUNEL assay using in situ Apoptosis Detection Kit (TaKaRa) according to the manufacturer's instructions. Brie¯y, collected cells were ®xed in PBS containing 4% formaldehyde and then blocked with methanol containing 0.3% hydrogen peroxide. After permeabilisation, cells were incubated with terminal deoxynucleotidyl transferase in the presence of FITC-labeled dUTP. Incorporated dUTPs in the apoptotic cells were detected by incubation with an HRP-conjugated anti-FITC antibody and visualized by Liquid DAB-Plus Substrate Kit (ZYMED) according to the manufacturer's instructions. The percentage of apoptotic cells was determined as 1006(the number of apoptotic cells relative to the total cell count). To examine the inhibition of apoptosis by ZAsp-CH 2 -DCB (Peptide Institute), cells (3610 5 ) were seeded into 60 mm dishes and transferred 24 h later to medium containing 0.1% FCS and 25 mg/ml Z-Asp-CH 2 -DCB.
Measurement of protease activity
Total cells (both adherent and detached) were collected and lysed with lysis buer (10 mM HEPES-KOH [pH 7.4], 2 mM EDTA, 0.1% CHAPS, 1 mM PMSF, 5 mM DTT) for 20 min on ice. After centrifugation, the supernatants were collected as lysates. For the measurement of protease activity, 10 mg of lysates diluted to 20 ml with lysis buer were mixed with 20 ml of 26ICE buer (40 mM HEPES-KOH [pH 7.4], 20% [v/v] glycerol, 1 mM PMSF, 4 mM DTT) containing 40 mM tetrapeptide substrate acetyl Asp-Glu-Val-Asp a-(4-methyl-coumaryl-7-amide) (Ac-DEVD-MCA) (Peptide Institute) and incubated at 378C for 1 h. After the addition of 1 ml of distilled water, thē uorescence of the reaction mixture was determined using a spectro¯uorometer. The excitation and emission wavelengths were 380 nm and 460 nm, respectively. One unit of protease activity was de®ned as the amount of enzyme required to release 1 pmol 7-amino-4-methyl-coumarin (AMC) per min at 378C.
